Target intelligence / Profile preview

Novel transcript, antisense to UPF3B (ENSG00000286366)

Target
ENSG00000286366
Molecular classification
Non-coding RNA, Long non-coding RNA (likely; based on transcript length and antisense orientation)
01

Overview

This locus encodes a non-coding RNA that is antisense to the UPF3B gene. UPF3B is a protein-coding gene integral to nonsense-mediated mRNA decay (NMD), which eliminates transcripts containing premature stop codons and serves as a critical mRNA quality control pathway[5][7]. The antisense transcript, LOC107985694 (ENSG00000286366), is annotated as a possible regulatory RNA but has not been characterized functionally or linked to disease or therapeutic interventions[1]. It does not produce a protein and its molecular or biological roles remain unclear. For structured information, this entry is best classified as a "non-coding RNA, antisense to UPF3B," with no evidence supporting its role as a therapeutic or druggable target. The locus is included in genomic databases as an annotated, uncharacterized transcript, and is not considered a canonical molecule for pharmacological investigation[1].

Other names
LOC107985694ENSG00000286366Novel antisense transcript to UPF3B
02

Mechanism of action

None established (no drugs target this molecule; mechanisms such as RNA interference or antisense modulation are theoretical and not documented for this transcript)

03

Biological functions

Other (function uncharacterized; typically, antisense non-coding RNAs may regulate their sense counterparts at a transcriptional or post-transcriptional level, but specific data for this locus is lacking)
04

Disease associations

Other (No direct evidence for disease association; however, UPF3B mutations are linked to neurodevelopmental diseases, but this antisense transcript itself has no established disease role)

Beyond the preview

Go deeper on Novel transcript, antisense to UPF3B (ENSG00000286366).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to UPF3B (ENSG00000286366).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call